Opaleye Management Inc.'s Form 4 filing
Protara Therapeutics, Inc. (TARA) · filed Dec 20, 2021
- Accession no.
- 0001493152-21-032025
- Filed
- Dec 20, 2021
- Trade date
- Dec 16-17, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market purchases total $66.9K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Opaleye Management Inc.CIK 0001595855 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 16, 2021 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +6,500 | $6.41F3 | +$41,665 | 2,493,206 | Indirect | |
| Dec 16, 2021 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +1,063 | $6.41F3 | +$6,813.83 | 103,710 | Indirect | |
| Dec 17, 2021 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +2,300 | $6.60F4 | +$15,180 | 2,495,506 | Indirect | |
| Dec 17, 2021 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +490 | $6.60F4 | +$3,234 | 104,200 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $6.41. The range of purchase prices on the transaction date was $6.35 to $6.49 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
Referenced by the price of 2 transactions in Table I.
- F4
The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $ 6.60. The range of purchase prices on the transaction date was $6.40 to $6.70 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
Referenced by the price of 2 transactions in Table I.